Menu Search
Equities

Aesthetic Medical International Holdings Group Ltd

3FMA:DEU

Aesthetic Medical International Holdings Group Ltd

Actions
  • Price (EUR)0.152
  • Today's Change0.015 / 10.95%
  • Shares traded0.00
  • 1 Year change-78.44%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Aesthetic Medical International Holdings Group Ltd is an investment holding company primarily engaged in the provision of aesthetic medical services. The Company mainly provides three kinds of medical services. The surgical aesthetic medical services comprise double eye lid surgery, rhinoplasty, breast augmentation, liposuction, facelifts and others. The non-surgical aesthetic medical services comprise minimally invasive aesthetic treatments and energy-based treatments. The general healthcare services and other aesthetic medical services comprise services in internal medicine and traditional Chinese medicine, aesthetic dentistry, aesthetic traditional Chinese medicine and hair loss treatments. The Company mainly conducts its business in the domestic market.

  • Revenue in USD (TTM)103.07m
  • Net income in USD-6.87m
  • Incorporated--
  • Employees1.29k
  • Location
    Aesthetic Medical International Holdings Group Ltd4068 Qiaoxiang Road, Nanshan DistrictSHENZHEN 518053ChinaCHN
  • Phone+86 9 176090333
  • Websitehttp://www.pengai.com.cn
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.